Key Highlights

  • Callan JMB (NASDAQ:CJMB) was up 12.42% to USD 0.3946, after a QuickStrip production line announcement.
  • Rockwell Medical (NASDAQ:RMTI) was up 11.04% at USD 7.67, after agreeing to acquire parts of Vantive's hemodialysis business.
  • Change Agents (NASDAQ:CHGA) was up 8.76% to USD 0.97, after joining Meta's Muse Developer Program.
  • Braiin (NASDAQ:BRAI) was up 10.40% to USD 2.76, with no announcement identified.
  • Primech Holdings (NASDAQ:PMEC) was up 11.12% at USD 0.3637, with no announcement identified.

Callan JMB (NASDAQ:CJMB) (up USD 0.0436, 12.42%): A Thin-Film Line Arrives

Callan JMB (NASDAQ:CJMB) was up 12.42% to USD 0.3946 in pre-market trading on November 3, 2026. On November 2, 2026, the company said it received a complete QuickStrip oral thin-film production line from Rapid Dose Therapeutics for its Texas facility.

Management said the platform could generate up to USD 15 million in Revenue in its first 18 months, but only if the equipment is successfully qualified. The release gave no installation timeline, equipment cost or margins. As a Penny Stock below USD 1, it can be volatile, thinly traded and exposed to dilution risk.

Rockwell Medical (NASDAQ:RMTI) (up USD 0.7626, 11.04%): A Dialysis Deal

Rockwell Medical (NASDAQ:RMTI) was up 11.04% at USD 7.67 in pre-market trading on November 3, 2026. The company signed a definitive agreement with Vantive to acquire its hemodialysis concentrates, monitors and water treatment systems, plus the Medolla, Italy plant. Dialyzers, including Theranova, are excluded.

Closing is expected in mid-2027, subject to regulatory approvals. The price and financing terms were not disclosed, and cash and investments were USD 24.8 million at June 30, 2026, so funding is an open question and Equity issuance could dilute holders. The company reports third quarter results on November 12, 2026.

Change Agents (NASDAQ:CHGA) (up USD 0.0781, 8.76%): Joining Meta's Muse Program

Change Agents (NASDAQ:CHGA) was up 8.76% to USD 0.97 in pre-market trading on November 3, 2026. A November 2, 2026 release said it joined the Muse Developer Program run by Meta Platforms (NASDAQ:META), a step toward connecting its Catch-Up and Beacon applications to Muse.

The company called this an initial step, with any integration subject to development, testing and approval. It regained Nasdaq minimum bid compliance on September 15, 2026 after a 1-for-20 reverse split, yet the price now sits under USD 1.00 again. Third-party data lists a float near 794,000 shares, which magnifies volatility.

Braiin (NASDAQ:BRAI) (up USD 0.2600, 10.40%): A Rebound Without a Fresh Headline

Braiin (NASDAQ:BRAI) was up 10.40% to USD 2.76 in pre-market trading on November 3, 2026, implying a prior close near USD 2.50 (calculated). No company announcement dated November 2 or November 3, 2026 was identified.

The latest catalyst is the October 26, 2026 expansion of its RADIUS platform with Force AI. Shares remain far below the 50-day average of USD 4.91. A financial news item indicated the company delayed its Annual Report because financial statements were incomplete, a point to verify in its filings. As a penny stock, price swings can be wide.

Primech Holdings (NASDAQ:PMEC) (up USD 0.0364, 11.12%): Robot Contract Headlines

Primech Holdings (NASDAQ:PMEC) was up 11.12% at USD 0.3637 in pre-market trading on November 3, 2026. No company release dated November 2 or 3, 2026 was identified, so the catalyst is not confirmed.

On October 29, 2026, the company announced a contract worth over USD 60,000 for one HYTRON restroom-cleaning robot and four years of maintenance at a Singapore mall. Robotics revenue was only about USD 12,000 in the fiscal year ended March 31, 2026. Trading below USD 1 carries added risk, including dilution from equity issuance.

Where Things Stand

The five names share a pre-market lift but not a cause. Callan JMB and Rockwell Medical have news dated this week, Change Agents is reacting to a program announcement from the previous session, and Braiin and Primech Holdings have no identified announcement. Items to watch include whether gains hold once regular trading opens, Rockwell Medical's purchase price and financing details, qualification of the QuickStrip line and any customer data from Beacon or Force AI.